Structure-function analyses reveal key molecular determinants of HIV-1 CRF01_AE resistance to the entry inhibitor temsavir

Structure-function analyses reveal key molecular determinants of HIV-1 CRF01_AE resistance to the entry inhibitor temsavir

Abstract The HIV-1 entry inhibitor temsavir prevents the viral receptor CD4 (cluster of differentiation 4) from interacting with the envelope glycoprotein (Env) and blocks its conformational changes. To do this, temsavir relies on the presence of a residue with small side chain at position 375 in En...

Full description

Bibliographic Details
Main Authors:	Jérémie Prévost, Yaozong Chen, Fei Zhou, William D. Tolbert, Romain Gasser, Halima Medjahed, Manon Nayrac, Dung N. Nguyen, Suneetha Gottumukkala, Ann J. Hessell, Venigalla B. Rao, Edwin Pozharski, Rick K. Huang, Doreen Matthies, Andrés Finzi, Marzena Pazgier
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-10-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-023-42500-2

Similar Items

Temsavir Modulates HIV-1 Envelope Conformation by Decreasing Its Proteolytic Cleavage
by: Marianne Boutin, et al.
Published: (2023-05-01)

Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies
by: Marianne Boutin, et al.
Published: (2022-06-01)

Across Functional Boundaries: Making Nonneutralizing Antibodies To Neutralize HIV-1 and Mediate Fc-Mediated Effector Killing of Infected Cells
by: Jonathan Richard, et al.
Published: (2021-10-01)

Effects of gp120 Inner Domain (ID2) Immunogen Doses on Elicitation of Anti-HIV-1 Functional Fc-Effector Response to C1/C2 (Cluster A) Epitopes in Mice
by: Rebekah Sherburn, et al.
Published: (2020-09-01)

Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins
by: Sai Priya Anand, et al.
Published: (2020-09-01)

HIV-1 Envelope Glycoprotein Cell Surface Localization Is Associated with Antibody-Induced Internalization
by: Sai Priya Anand, et al.
Published: (2021-09-01)

Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam.
by: Liao, H, et al.
Published: (2009)

Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2
by: Shang Yu Gong, et al.
Published: (2022-09-01)

Incorporating the Cluster A and V1V2 Targets into a Minimal Structural Unit of the HIV-1 Envelope to Elicit a Cross-Clade Response with Potent Fc-Effector Functions
by: Rebekah Sherburn, et al.
Published: (2021-08-01)

Phylodynamics of major CRF01_AE epidemic clusters circulating in mainland of China
by: Xiaolin Wang, et al.
Published: (2017-07-01)

Transmission network and phylogenetic analysis reveal older male-centered transmission of CRF01_AE and CRF07_BC in Guangxi, China
by: Fei Zhang, et al.
Published: (2023-12-01)

MOLECULAR EPIDEMIOLOGICAL ANALYSIS OF THE TRANSMISSION CLUSTERS OF THE HIV-1 CIRCULATING RECOMBINANT FORMS CRF01_AE AND CRF02_ AG IN BULGARIA
by: Ivailo Alexiev, et al.
Published: (2020-05-01)

Characterization of two novel HIV-1 second-generation recombinants (CRF01_AE/CRF07_BC) identified in Hebei Province, China
by: Xuegang Yang, et al.
Published: (2023-05-01)

Susceptibility of HIV-1 subtypes B', CRF07_BC and CRF01_AE that are predominantly circulating in China to HIV-1 entry inhibitors.
by: Xiaoling Yu, et al.
Published: (2011-03-01)

Cross-Continental Dispersal of Major HIV-1 CRF01_AE Clusters in China
by: Minghui An, et al.
Published: (2020-01-01)

HIV-1 Envelope Glycoproteins Proteolytic Cleavage Protects Infected Cells from ADCC Mediated by Plasma from Infected Individuals
by: Jérémie Prévost, et al.
Published: (2021-11-01)

Multiple CRF01_AE/CRF07_BC Recombinants Enhanced the HIV-1 Epidemic Complexity Among MSM in Shenyang City, Northeast China
by: Shan He, et al.
Published: (2022-05-01)

High rates of tenofovir failure in a CRF01_AE-predominant HIV epidemic in the Philippines
by: Edsel Maurice T. Salvana, et al.
Published: (2020-06-01)

Phylogenetic and temporal dynamics of human immunodeficiency virus type 1 CRF01_AE in China.
by: Jingrong Ye, et al.
Published: (2013-01-01)

High prevalence of CXCR4 usage among treatment-naive CRF01_AE and CRF51_01B-infected HIV-1 subjects in Singapore
by: Ng Kah Ying, et al.
Published: (2013-02-01)

Emergence of HIV-1 CRF01AE/B unique recombinant forms in Kuala Lumpur, Malaysia
by: Tee, K.K., et al.
Published: (2005)

DRUG RESISTANCE MUTATIONS AND TRANSMISSION CLUSTERS OF THE HIV-1 CRF01_AE SUB-EPIDEMIC IN BULGARIA
by: Lyubomira Grigorova, et al.
Published: (2022-02-01)

The Molecular Epidemiological and Immunological Characteristics of HIV-1 CRF01_AE/B Recombinants in Nanjing, China
by: You Ge, et al.
Published: (2022-07-01)

Correction: The Effect of HLA Polymorphisms on the Recognition of Gag Epitopes in HIV-1 CRF01_AE Infection
Published: (2014-01-01)

Multiple independent introductions of HIV-1 CRF01_AE identified in China: what are the implications for prevention?
by: Yassir F Abubakar, et al.
Published: (2013-01-01)

Limited Sustained Local Transmission of HIV-1 CRF01_AE in New South Wales, Australia
by: Francesca Di Giallonardo, et al.
Published: (2019-05-01)

Intrapatient Development of Multi-Class Drug Resistance in an Individual Infected with HIV-1 CRF01_AE
by: Peng X, et al.
Published: (2021-08-01)

Correction: The Effect of HLA Polymorphisms on the Recognition of Gag Epitopes in HIV-1 CRF01_AE Infection.
Published: (2014-01-01)

Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection
by: Alexandra Tauzin, et al.
Published: (2022-03-01)

Geographic Transmission and Epidemic History of HIV-1 CRF01_AE, CRF07_BC, and HCV Subtype-6w among Taiwanese Persons Who Inject Drugs
by: Yen-Ju Chen, et al.
Published: (2022-09-01)

Elicitation of Cluster A and Co-Receptor Binding Site Antibodies Are Required to Eliminate HIV-1 Infected Cells
by: Guillaume Beaudoin-Bussières, et al.
Published: (2020-05-01)

The molecular basis of the neutralization breadth of the RBD-specific antibody CoV11
by: William D. Tolbert, et al.
Published: (2023-06-01)

HLA-B1302 is associated with viral control in clade CRF01_AE HIV-1 infection in Thailand
by: Hempel, U, et al.
Published: (2009)

Molecular Epidemiological Analysis of the Origin and Transmission Dynamics of the HIV-1 CRF01_AE Sub-Epidemic in Bulgaria
by: Ivailo Alexiev, et al.
Published: (2021-01-01)

Tracing the epidemic history of HIV-1 CRF01_AE clusters using near-complete genome sequences
by: Xingguang Li, et al.
Published: (2017-06-01)

HIV-1 CRF01_AE strain is associated with faster HIV/AIDS progression in Jiangsu Province, China
by: Minjie Chu, et al.
Published: (2017-05-01)

Effects of Temsavir, Active Moiety of Antiretroviral Agent Fostemsavir, on QT Interval: Results From a Phase I Study and an Exposure–Response Analysis
by: Chakradhar Lagishetty, et al.
Published: (2020-07-01)

The rapidly expanding CRF01_AE epidemic in China is driven by multiple lineages of HIV-1 viruses introduced in the 1990s.
by: Feng, Y, et al.
Published: (2013)

Mutations in the V1 domain of Thai CRF01-AE viruses that confer sensitivity/resistance to broadly neutralizing antibodies
by: O'Rourke S, et al.
Published: (2012-09-01)

Structural Basis for Epitopes in the gp120 Cluster A Region that Invokes Potent Effector Cell Activity
by: William D. Tolbert, et al.
Published: (2019-01-01)